regorafenib

Phase 3

Phase 3

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

1 competitor in GIST

Drug Information

Target Indication

GIST

Clinical Trial

Last updated: 12/4/2025

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

BPMC

Blueprint Medicines Corporation

Related Pipeline

Indolent Systemic Mastocytosis

Solid Tumor, Unspecified, Child

Chronic Inducible Urticaria

Advanced Solid Tumor

Hepatocellular Carcinoma

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts